Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, Affymetrix, Qiagen, Beckton Dickinson, Agilent, BioMicro Systems

Premium

Sequenom this week launched iPlex, a new multiplexing SNP-genotyping assay that is compatible with the company's PCR-based MassArray System platform for genetic analysis.

The San Diego-based company said that iPlex is aimed at reducing cost, time, and yield for limited SNP sets, and would be useful for clinical research and microarray data validation.


Affymetrix last week launched its new GeneChip Globin-Reduction Kits and associated reagents.

The new kits were developed with PreAnalytiX — a joint venture between Qiagen and Beckton Dickinson — and use the PreAnalytiX PAXgene Blood RNA System to improve gene expression profile results of cellular RNA extracted from whole blood.

The kits and reagents allow researchers to reduce globin messenger RNA, which often interferes with gene expression associated with white blood cells and increases assay sensitivity.


Agilent last week rolled out its Laboratory Resource Management (LRM) service for life science and pharmaceutical laboratories.

The Palo Alto, Calif.-based company will now place its technical engineers on site to handle maintenance, repair, regulatory compliance, and workflow consulting.

The company claims the goal of LRM is to increase user productivity and reduce instrument downtime.


BioMicro Systems last week launched its MAUI 12-Bay Hybridization System, the company said.

The MAUI 12-Bay System is designed to meet the high-throughput needs of microarray labs and can process 12 microarray slides at once, achieve an increase in sensitivity with low-sample volumes, and cut time off the hybridization process, BioMicro Systems claimed.

The system is the latest addition to the company's MAUI product line that includes the MAUI 4-Bay Hybridization System and its line of MAUI Mixer hybridization chambers.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.